COMPANY NAME	REVENUES 12 Months Ending Q2 2026	MARKET SHARE 12 Months Q2 2026	MARKET SHARE MRQ Q2 2026	MARKET SHARE A Quarter Before Q1 2026
Elite Health Systems Inc	3.49	0.00%	0.00 %	0.00 %
Abbott Laboratories	45,134.00	36.98%	35.94%	37.47%
Medtronic Plc	37,542.00	30.76%	31.41%	32.07%
Stryker Corp	25,837.00	21.17%	21.21%	19.69%
Zimmer Biomet Holdings Inc	8,508.80	6.97%	7.01%	6.82%
Neurocrine Biosciences Inc	3,373.90	2.76%	3.09%	2.66%

1 more competitors available

USNU's Market share relative to its competitors, as of Q2 2026 within the Healthcare Sector

As of Q2 2026

COMPANY NAME	MARKET SHARE 12 Months Ending Q2 2026	MARKET SHARE 12 Months Ending Q1 2026	MARKET SHARE MRQ Q2 2026	MARKET SHARE Q1 2026
Elite Health Systems Inc	0.00%	0.00%	0.00 %	0.00 %
Abbott Laboratories	36.98%	37.91%	35.94%	37.47%
Medtronic Plc	30.76%	29.72%	31.41%	32.07%
Stryker Corp	21.17%	21.48%	21.21%	19.69%
Zimmer Biomet Holdings Inc	6.97%	7.04%	7.01%	6.82%
Neurocrine Biosciences Inc	2.76%	2.45%	3.09%	2.66%

1 more companies available

Note: Market share is calculated based on total revenue. To get a more accurate picture of Elite Health Systems Inc's market divisions, geographic dispersion, segments, products, and services, visit Elite Health Systems Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.